RAGE mRNA expression in the diabetic mouse kidney

Molecular and Cellular Biochemistry

Volumn 170, Issue 1-2, 1997, Pages 147-152

  Ziyadeh, Fuad N ^a   Cohen, Margo P ^a   Guo, Jia ^a   Jin, Yulin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes; Glycation; Nephropathy; RAGE; Receptors

Indexed keywords

ALBUMIN; MESSENGER RNA; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FLUORESCENCE; GENE EXPRESSION; GLYCATION; KIDNEY; KIDNEY CORTEX; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN URINE LEVEL; STEADY STATE;

EID: 0030895487     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006857520122     Document Type: Article

References (44)

1. Cohen MP: Diabetes and Protein Glycosylation: Measurement and Biologic Relevance. Springer Verlag, New York, 1986
2. Brownlee M, Vlassara H, Cerami A: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med 318: 1315-1321, 1988
3. Bucala R, Cerami A, Vlassara H: Advanced glycosylation end products in diabetic complications. Diabetes Rev 3: 258-268, 1995
4. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM: The biosynthesis of human hemoglobin Ale: Slow glycosylation of hemoglobin in vivo. J Clin Invest 57: 1652-1659, 1976
5. Bunn HF, Gabbay KH, Gallop P: The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science 20: 21-27, 1978
6. Cohen MP, Hud E: Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELIS A. J Immunol Meth 122: 279-283, 1989
7. Monnier VM, Sell SR, Miyata S, Nagaraj RH, Odetti P, Lapolla A: Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia: Relevance to diabetic nephropathy. Acta Diabetologia 29: 130-135, 1992
8. Vlassara H, Brownlee M, Cerami A: High affinity receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82: 5588-5592, 1985
9. Radoff S, Cerami A, Vlassara H: Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7. Diabetes 39: 1510-1518, 1990
10. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpol P, Suthanthiran M, Vlassara H: Two novel rat liver membrane proteins that bind advanced glycosylation end products: Relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174: 515-524, 1994
11. Westwood ME, McClellan AC, Thornalley PJ: Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. J Biol Chem 269: 32293-32298, 1994
12. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan Y-CE, Tsang TG, Stern D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997, 1992
13. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan Y-C, Elliston K, Stern D, Shaw A: Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992
14. Schmidt AM, Hori O, Brett J, Yan SD, Wautier J-L, Stern D: Cellular receptors for advanced glycation end products. Arterioscler Thromb 14: 1521-1528, 1994
15. Brett J, Schmidt AM, Zou Y-S, Yan SD, Weidman E, Pinsky D, Neeper M, Przysiecki C, Shaw A, Mighele A, Stern D: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712, 1993
16. Miki S, Kasayama S, Miki Y, Nakamura Y, Yamamoto M, Sato B, Kishimoto T: Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro. Biochem Biophys Res Comm 196: 984-989, 1993
17. Lin S, Huang Y: Organ distribution of receptor for advanced glycation end products (RAGE) mRNA and the effect of hyperglycemia on it. J Am Soc Nephrol 6: 1043A, 1995
18. Gilcrease MZ, Hoover RL: Activated human monocytes exhibit receptor-mediated adhesion to a non-enzymatically glycosylated protein substrate. Diabetologia 33: 160-164, 1992
19. Gilcrease MZ, Hoover RL: Human monocyte interactions with non-enzymatically glycated collagen. Diabetologia 35: 160-164, 1992
20. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D: Regulation of human mononuclear phagocytic migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 91: 2155-2168, 1993
21. Wauter J-L, Wautier M-P, Schmidt AM, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan S-D, Brett J, Guillausseau P-J, Stern D: Advanced glycation end products (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91: 7742-7746, 1994
22. Yan S-D, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994
23. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96: 1395-1403, 1995
24. Schmidt AM, Haus M, Popov D, Zhang J-H, Yan S-D, Brett J, Cao R, Kuwabara K, Costache G, Simionescu N, Simionescu M, Stern D: The receptor for advanced glycation endproducts (AGEs) has a central role in vessel wall interaction and gene activation in response to AGEs in the intravascular space. Proc Natl Acad Sci USA 91: 8807-8811, 1994
25. Like AA, Lavine RL, Poffenbarger PL, Chick WL: Studies in the diabetic mutant mouse. Amer J Path 66: 193-204, 1972
26. Cohen MP, Hud E, Wu VY: Amelioration of diabetic nephropathy with monoclonal antibodies against glycated albumin. Kidney Int 45: 1673-1679, 1994
27. Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists: A novel treatment strategy. J Clin Invest 95: 2338-2345, 1995
28. Cohen MP, Clements RS, Hud E, Cohen JA, Zivadeh FN: Evolution of renal functional abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exper Nephrol 4: 166-171, 1996
29. Cohen MP, Clements RS, Cohen JA, Shearman CW: Prevention of decline in renal function in the diabetic db/db mouse. Diabetologia 39: 270-274, 1996
30. Vlassara H, Brownlee M, Cerami A: Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37: 456-461, 1988
31. Kovanen PI, Brown SM, Basu SK, Bilheimer DW, Goldstein JL: Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci USA 78: 1396-1400, 1981
32. Hui DY, Innearity TL, Mahley RW: Lipoprotein binding to canine hepatic membranes. J Biol Chem 256: 5646-5655, 1981
33. Stoudmire JB, Renaud G, Shames DM, Havel RJ: Impaired receptor-mediated catabolism of low density lipoproteins in fasted rabbits. J Lipid Res 25: 33-39, 1984
34. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez R, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Amer J Physiol 259: F704-714, 1990
35. Cohen MP, Ziyadeh FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475-484, 1994
36. Cohen MP, Hud E: Production and characterization of monoclonal antibodies against human glycoalbumin. J Immunol Meth 117: 121-129, 1989
37. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products. J Biol Chem 267: 5133-5138, 1992
38. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41: 1520-1527, 1992
39. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267: F1094-F1101, 1994
40. Nakamura R, Fukui M, Ebihara I, Osada S, Nagaoka J, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456, 1993
41. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF- β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
42. Lane PH, Steffes MW, Fioretto P, Maurer SM: Renal interstitial expansion in insulin-dependent diabetes. Kidney Int 43: 661-667, 1993
43. Ziyadeh FN: Renal tubular basement membrane and collagen IV in diabetes mellitus. Kidney Int 43: 114-120, 1993
44. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22: 736-744, 1993